600
Participants
Start Date
November 1, 2025
Primary Completion Date
July 14, 2030
Study Completion Date
July 14, 2030
transdermal nicotine replacement therapy
All participants will receive transdermal nicotine replacement therapy (21 mg. patches)
Duke University Medical Center, Durham
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Duke University
OTHER